Anti-TNF dose escalation and drug sustainability in Crohn's disease Data from the nationwide administrative database in Hungary /
A significant percentage of patients receiving anti-tumor necrosis factor alpha (anti-TNFα) agents lose clinical response over time. This study aims to provide representative real-world data on anti-TNFα drug sustainability, prevalence and predictors of anti-TNFα dose escalation.In this nationwide,...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2020
|
| Sorozat: | DIGESTIVE AND LIVER DISEASE
52 No. 3 |
| doi: | 10.1016/j.dld.2019.09.020 |
| mtmt: | 30886177 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/18628 |